1st Quarter - Report

THE DUBERSTEIN GROUP INC. for AMGEN INC

Firm
Client
Income
$62,500
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Research and experimentation tax incentives and international tax issues, including: Administration's FY 2014 corporate tax proposals. Tax reform, including House Ways and Means and Senate Finance discussion draft.

LobbyistCovered position, as disclosed
DANIEL P MEYER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Sustainable growth rate - S 2000, SGR Repeal and Medicare Provider Payment Modernization Act of 2014; S 2122, Responsible Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014; HR 2810, Medicare Patient Access and Quality Improvement Act of 2013; HR 4015, SGR Repeal and Medicare Provider Payment Modernization Act of 2014; HR 4302, Protecting Access to Medicare Act of 2014.

LobbyistCovered position, as disclosed
DANIEL P MEYER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4302 (113th), H.R. 4015 (113th), H.R. 2810 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.